WallStreetZenWallStreetZen

NASDAQ: RGNX
Regenxbio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RGNX

Based on 8 analysts offering 12 month price targets for Regenxbio Inc.
Min Forecast
$21.00+30.35%
Avg Forecast
$40.38+150.62%
Max Forecast
$55.00+241.4%

Should I buy or sell RGNX stock?

Based on 8 analysts offering ratings for Regenxbio Inc.
Strong Buy
Strong Buy
3 analysts 37.5%
Buy
4 analysts 50%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RGNX stock forecasts and price targets.

RGNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-03-11
lockedlocked$00.00+00.00%2024-03-08
lockedlocked$00.00+00.00%2024-03-07
lockedlocked$00.00+00.00%2024-03-07Find Out Why
Baird
Top 13%
88
BuyMaintains$39.00+142.09%2024-03-06
Wedbush
Top 8%
93
HoldReiterates$21.00+30.35%2024-02-28
Raymond James
Bottom 4%
4
BuyReinstates$45.00+179.33%2024-02-21

1 of 1

Forecast return on equity

Is RGNX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is RGNX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RGNX revenue forecast

What is RGNX's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$146.7M+62.52%
Avg 2 year Forecast
$164.9M+82.75%
Avg 3 year Forecast
$252.2M+179.48%
RGNX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RGNX revenue growth forecast

How is RGNX forecast to perform vs Biotechnology companies and vs the US market?
Company
38.26%
Industry
37.96%
Market
10.23%
RGNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RGNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RGNX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RGNX$16.11$40.38+150.62%Strong Buy
NRIX$14.44$21.33+47.74%Buy
ARCT$26.32$63.25+140.31%Strong Buy
ELVN$17.67$34.00+92.42%Strong Buy
PLRX$12.19$46.67+282.83%Buy
View Top Biotech Stocks

Regenxbio Stock Forecast FAQ

Is Regenxbio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: RGNX) stock is to Strong Buy RGNX stock.

Out of 8 analysts, 3 (37.5%) are recommending RGNX as a Strong Buy, 4 (50%) are recommending RGNX as a Buy, 1 (12.5%) are recommending RGNX as a Hold, 0 (0%) are recommending RGNX as a Sell, and 0 (0%) are recommending RGNX as a Strong Sell.

If you're new to stock investing, here's how to buy Regenxbio stock.

What is RGNX's revenue growth forecast for 2024-2026?

(NASDAQ: RGNX) Regenxbio's forecast annual revenue growth rate of 38.26% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Regenxbio's revenue in 2024 is $90,242,000.On average, 7 Wall Street analysts forecast RGNX's revenue for 2024 to be $6,515,745,216, with the lowest RGNX revenue forecast at $3,554,204,400, and the highest RGNX revenue forecast at $12,651,190,562. On average, 6 Wall Street analysts forecast RGNX's revenue for 2025 to be $7,326,814,660, with the lowest RGNX revenue forecast at $3,554,204,400, and the highest RGNX revenue forecast at $10,707,040,755.

In 2026, RGNX is forecast to generate $11,204,807,081 in revenue, with the lowest revenue forecast at $8,953,485,159 and the highest revenue forecast at $16,753,630,991.

What is RGNX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RGNX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RGNX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year RGNX price target, the average RGNX price target is $40.38, with the highest RGNX stock price forecast at $55.00 and the lowest RGNX stock price forecast at $21.00.

On average, Wall Street analysts predict that Regenxbio's share price could reach $40.38 by Apr 12, 2025. The average Regenxbio stock price prediction forecasts a potential upside of 150.62% from the current RGNX share price of $16.11.

What is RGNX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RGNX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.